Access the full text.
Sign up today, get DeepDyve free for 14 days.
M. Eison, A. Eison (1984)
Buspirone as a midbrain modulator: Anxiolysis unrelated to traditional benzodiazepine mechanismsDrug Development Research, 4
JC Borrus (1957)
Study of effect of Miltown on psychiatric statesJournal of American Medical Association, 157
M. Smith, J. Chassan (1964)
COMPARISONS OF DIAZEPAM, CHLORPROMAZINE AND TRIFLUOPERAZINE IN A DOUBLE-BLIND CLINICAL INVESTIGATION.Journal of neuropsychiatry, 5
J. Wittenborn (1966)
The clinical psychopharmacology of anxiety
(1970)
The Long Road for a Drug from Idea to Use
L Lasagna (1956)
A study of hypnotic drugs in chronic diseaseJournal of Chronic Disease, 3
G. Farrar, A. Krosnick (1990)
Milestones in clinical pharmacology. Obesity.Clinical therapeutics, 12 5
F. Berger (1957)
THE CHEMISTRY AND MODE OF ACTION OF TRANQUILIZING DRUGSAnnals of the New York Academy of Sciences, 67
P. Deniker
CHAPTER 12 Introduction of Neuroleptic Chemotherapy Into Psychiatry
H. Beckman (1957)
Meprobamate and other agents used in mental disturbances; introductory remarks.Annals of the New York Academy of Sciences, 67 10
M. Johns (1977)
Self-poisoning with barbiturates in England and Wales during 1959-74.British Medical Journal, 1
P. Cooper (1979)
The benzodiazepines.Midwife, health visitor & community nurse, 15 8
VG Laties, B Weiss (1958)
A critical review of the efficacy of meprobamate in the treatment of anxietyJournal of Chronic Disease, 7
(1998)
Farmacos ansioliticos, sedantes e hipnoticos
(1984)
Anxiety and the discovery of the tranquillizers
R. Katz (1972)
Sedatives and tranquilizers.The New England journal of medicine, 286 14
GE Farrar (1991)
Milestones in clinical pharmacologyPsychopharmacology of depression and anxiety. Clinical Therapeutics, 13
(1970)
The impact of biological psychiatry
V. Laties, Bernard Weiss (1958)
A critical review of the efficacy of meprobamate (miltown, equanil) in the treatment of anxiety.Journal of chronic diseases, 7 6
C. Cahn (1999)
A History of Psychiatry: From the Era of the Asylum to the Age of ProzacThe Journal of Clinical Psychiatry, 60
F. Berger, W. Bradley (1946)
THE PHARMACOLOGICAL PROPERTIES OF α: β DIHYDROXY‐γ‐(2‐METHYLPHENOXY)‐PROPANE (MYANESIN)British journal of pharmacology and chemotherapy, 1
F. López-Muñoz, C. Álamo, G. Rubio, E. Cuenca (2004)
Half a century since the clinical introduction of chlorpromazine and the birth of modern psychopharmacologyProgress in Neuro-Psychopharmacology and Biological Psychiatry, 28
VM Pennington (1957)
Use of Miltown with psychotic patientsAmerican Journal of Psychiatry, 114
(1990)
History of the treatment of anxiety
HD Fabing (1955)
Frenquel a blocking agent against experimental LSD-25 and mescaline psychosis. Preliminary note on its clinical applicationNeurology, 5
F. Berger (1952)
The anticonvulsant activity of carbamate esters of certain 2,2-disubstituted-1,3-propanediols.The Journal of pharmacology and experimental therapeutics, 104 2
M. Herman, S. Nagler (1954)
Psychoses due to amphetamine.The Journal of nervous and mental disease, 120 3-4
FM Berger (1952)
The anticonvulsant activity of carbamate esters of certain of 2, 2-disubstituted-l, 3-propanediolsJournal of Pharmacological Therapy, 104
L. Selling (1955)
Clinical study of a new tranquilizing drug; use of miltown (2-methyl-2-n-propyl-1,3-propanediol dicarbamate).Journal of the American Medical Association, 157 18
G. Farrar (1991)
Milestones in clinical pharmacology. Psychopharmacology--depression and anxiety.Clinical therapeutics, 13 4
B. Ludwig, J. Potterfield (1971)
The pharmacology of propanediol carbamates.Advances in pharmacology and chemotherapy, 9
(1970)
Psychopharmacology: On Beginning in a New Science. In Discoveries in Biological Psychiatry
H. Fabing (1955)
Frenquel, a Blocking Agent Against Experimental LSD‐25 and Mescaline PsychosisNeurology, 5
A. Lugg (1985)
The Process of DiscoveryPhilosophy of Science, 52
F. Jones (1973)
Origins of Psychopharmacology from CPZ to LSDMilitary Medicine, 138
F. Berger (1947)
The mode of action of myanesin.British journal of pharmacology and chemotherapy, 2 4
FM Berger (1957)
Meprobamate and other agents used in mental disordersAnnals of NY Academy of Sciences, 67
F. Mallinson (1947)
A new synthetic curarising agent in anaesthesia.Lancet, 1 6438
L. Hollister (1983)
The pre-benzodiazepine era.Journal of psychoactive drugs, 15 1-2
J. Quilliam (1968)
Drugs and the MindNature, 218
F. Berger, W. Bradley (1946)
The pharmacological properties of alpha:beta dihydroxy-gamma-(methylphenoxy)-propane (myanesin).British journal of pharmacology and chemotherapy, 1 4
F. Mallinson (1947)
A NEW SYNTHETIC CURARISING AGENT IN ANESTHESIAThe Lancet, 249
J. Brougher (1960)
The treatment of emotional disorders in obstetrics and gynecology with thioridazine.Quarterly review of surgery, obstetrics and gynecology, 17
LS Selling, PH Orlando (1957)
Clinical study of a new tranquilizing drugJournal of American Medical Association, 157
T. Jerram (1986)
Hypnotics and sedatives, 10
L. Lasagna (1956)
A study of hypnotic drugs in patients with chronic diseases; comparative efficacy of placebo; methyprylon (noludar) meprobmate (miltown, equanil) pentobarbial; phenobarbital; secobarbital.Journal of chronic diseases, 3 2
Brougher Jc (1960)
The treatment of emotional disorders in obstetrics and gynecology with thioridazine., 17
V. Pennington (1957)
Use of Miltown (meprobamate) with psychotic patients.The American journal of psychiatry, 114 3
Smith Me, Chassan Jb (1964)
COMPARISONS OF DIAZEPAM, CHLORPROMAZINE AND TRIFLUOPERAZINE IN A DOUBLE-BLIND CLINICAL INVESTIGATION.Journal of Neuropsychiatry and Clinical Neurosciences, 5
J. Borrus (1955)
Study of effect of miltown (2-methyl-2-n-propyl-1,3-propanediol dicarbamate) on psychiatric states.Journal of the American Medical Association, 157 18
D. Greenblatt, R. Shader (1971)
Meprobamate: a study of irrational drug use.The American journal of psychiatry, 127 10
F. Shideman (1958)
Hypnotics and sedatives.Postgraduate medicine, 24 3
P. Seeman (2002)
The Creation of PsychopharmacologyNature Medicine, 8
D. Goldman (1955)
Treatment of psychotic states with chlorpromazine.Journal of the American Medical Association, 157 15
B. Ludwig, E. Piech (1951)
Some Anticonvulsant Agents Derived from 1,3-PropanediolsJournal of the American Chemical Society, 73
Meprobamate was the first successful anti-anxiety drug of the modern era. On the 50th anniversary of its introduction, the authors trace the development of its synthesis, marketing and runaway success to understand the scientific and socio-political factors that may have shaped its use in clinical psychiatry. The relationship of this drug to the earlier development of chlorpromazine is explored to clarify the imperatives of drug classification in modern psychiatry.
Psychiatric Quarterly – Springer Journals
Published: Jan 1, 2006
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.